Myriad Genetics (MYGN) Stock Highlights

27.59 | +4.55%

2024-09-16 02:19:12

Myriad Genetics is a molecular diagnostics company that provides testing services designed to assess an individuals risk of developing a disease. The firm produces MyRisk, a 35-gene panel with the capability to identify the elevated risk of developing eight types of cancer. Other diagnostic products include BRACAnalysisCDx, the FDA-approved companion diagnostic for PARP inhibitors; GeneSight, which helps improve responses to psychotropic drugs for patients suffering from depression; Prequel, with is a noninvasive prenatal test; and Prolaris, which identifies prostate cancer patients that can pursue active surveillance. The firm offers biomarker discovery and companion diagnostic services to pharma and biotech companies

Statistics

Range Today

26.5 27.84

Volume Today 733K

Range 1 Year

13.82 29.08

Volume 1 Year 178.63M

Range 3 Year

13.82 35.31

Volume 3 Year 459.63M

Range 10 Year

9.24 50.44

Volume 10 Year 2.17B

Highlights

Market Capitalization 2.51B (mid)

Floating Shares 83.23M

Current Price 27.59

Price To Earnings -14.97

Price To Revenue 3.04

Price To Book 3.39

Earnings Per Share -1.77

Payout Ratio 0%

Performance

Latest +4.55%

1 Month -2.47%

3 Months +18.26%

6 Months +27.08%

1 Year +68.85%

3 Years -16.9%

5 Years -1.08%

10 Years -23.45%

Benchmarks

Market Capitalization

28 / 58

Gross Profits

22 / 52

Total Revenue

25 / 57

Total Rank

23 / 58

Free Cashflow

42 / 56

Performance 5 years

28 / 58

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.